- Home
- M vs PLXS Comparison
M vs PLXS Comparison
Compare M & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | M | PLXS |
|---|---|---|
| Founded | 1830 | 1979 |
| Country | United States | United States |
| Employees | N/A | 20000 |
| Industry | Department/Specialty Retail Stores | Electrical Products |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.0B |
| IPO Year | 2003 | 1995 |
Fundamental Metrics
Financial Performance| Metric | M | PLXS |
|---|---|---|
| Price | $24.12 | $248.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | $20.09 | ★ $206.50 |
| AVG Volume (30 Days) | ★ 5.5M | 264.4K |
| Earning Date | 05-27-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | 12.08 | ★ 56.11 |
| EPS | 0.23 | ★ 3.32 |
| Revenue | ★ $22,621,000,000.00 | N/A |
| Revenue This Year | N/A | $14.31 |
| Revenue Next Year | N/A | $8.29 |
| P/E Ratio | $104.72 | ★ $75.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.77 | $115.83 |
| 52 Week High | $26.10 | $307.06 |
Technical Indicators
Market Signals| Indicator | M | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 33.52 |
| Support Level | $22.06 | $239.59 |
| Resistance Level | $24.22 | $300.15 |
| Average True Range (ATR) | 0.80 | 11.98 |
| MACD | -0.08 | -4.70 |
| Stochastic Oscillator | 53.07 | 0.00 |
Price Performance
Historical ComparisonAbout M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.